logo
Select company
Select metric
$ -38.92MConsolidated Income
VS
Market
22
Sector
44
Industry
56
History
68
$ 1.54Close
$ 1.16 - $ 5.45 52-Week Range
Ticker Information

Ticker

CRIS

Company Name

CURIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CURIS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CRIS - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -38.92M
3/31/2025$ -42.13M
12/31/2024$ -43.39M
9/30/2024$ -45.48M
6/30/2024$ -47.57M
3/31/2024$ -47.73M
12/31/2023$ -47.41M
9/30/2023$ -47.03M
6/30/2023$ -48.14M
3/31/2023$ -52.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CURIS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -31M.
  • Over the past 5 years, CURIS INC's average Cons. Inc. has been $ -44.7M.
  • The median Cons. Inc. for CURIS INC during this period was $ -46.26M
  • CURIS INC reached its highest Cons. Inc. over the past 5 years at $ -29.91M.
  • The lowest Cons. Inc. recorded by CURIS INC in the same timeframe $ -58.96M

CURIS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
BCAB : BIOATLA INC $ -59.52MCARM : CARISMA THERAPEUTICS INC $ -49.38MCSCIF : COSCIENS BIOPHARMA INC $ -18.84MNXGL : NEXGEL INC $ -2.9MHCTI : HEALTHCARE TRIANGLE INC $ -5.67MMRKR : MARKER THERAPEUTICS INC $ -14.61MJAGX : JAGUAR HEALTH INC $ -41.41MLPCN : LIPOCINE INC $ -4.51MNRXS : NEURAXIS INC $ -7.17MRLYB : RALLYBIO CORP $ -41.65M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

CRIS - Consolidated Income, Last 5 years

$ -58.96M

Minimum

Sep 30, 2022

$ -29.91M

Maximum

Dec 31, 2020

$ -44.7M

Average

$ -46.26M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M